Your browser doesn't support javascript.
loading
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.
Saburi, Ahmad; Kahrizi, Mohammad Saeed; Naghsh, Navid; Etemadi, Hasti; Ilhan, Ahmet; Adili, Ali; Ghoreishizadeh, Shadi; Tamjidifar, Rozita; Akbari, Morteza; Ercan, Gülinnaz.
Afiliación
  • Saburi A; Department of Biology, Faculty of Basic Sciences, Gonbad Kavous University, Gonbad Kavous, Iran.
  • Kahrizi MS; Department of Surgery, Alborz University of Medical Sciences, Karaj, Alborz, Iran.
  • Naghsh N; Department of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Etemadi H; Department of Biotechnology, Rajiv Gandhi Institute of IT and Biotechnology, Bharati Vidyapeeth University, Pune, India.
  • Ilhan A; Department of Medical Biochemistry, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Adili A; Senior Adult Oncology Department, Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA.
  • Ghoreishizadeh S; Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tamjidifar R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Akbari M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ercan G; Department of Medical Biochemistry, Faculty of Medicine, Ege University, Izmir, 35100, Turkey.
J Ovarian Res ; 15(1): 81, 2022 Jul 07.
Article en En | MEDLINE | ID: mdl-35799305

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / MicroARNs / Antineoplásicos Límite: Female / Humans Idioma: En Revista: J Ovarian Res Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / MicroARNs / Antineoplásicos Límite: Female / Humans Idioma: En Revista: J Ovarian Res Año: 2022 Tipo del documento: Article País de afiliación: Irán